Presentation of the French Network of Paediatric Clinical Investigation Centres (CIC.P)

Fundamental and Clinical Pharmacology

Volumn 21, Issue 2, 2007, Pages 105-110

  Jacqz Aigrain, Evelyne ^f   Kassai, Behrouz ^b,i   Libersa, Christian ^a   Gottrand, Fréderic ^a   Desplanque, Dominique ^a   Gueyffier, François ^b   Cornu, Catherine ^b   Petit, Pierre ^c   Galtier, Florence ^c   Galmiche, Jean Paul ^d   Rozé, Jean Christophe ^d   Sacher Huvelin, Sylvie ^d   Hankard, Regis ^e   Denjean, André ^f   Wang, Ying ^f   Bousquet, Pascal ^g   Brandt, Christian ^g   Laugel, Vincent ^g   Goupille, Philippe ^h   Halimi, Jean Michel ^h   Labarthe, François ^h   more..

^a LILLE UNIVERSITY HOSPITAL   (France)

^b Inserm   (France)

^c HÔPITAL SAINT ELOI   (France)

^d HÔTEL DIEU   (France)

^e POITIERS UNIVERSITY HOSPITAL   (France)

^f HÔPITAL ROBERT DEBRÉ   (France)

^g Université de Strasbourg   (France)

^h CHU BRETONNEAU   (France)

ⁱ LOUIS PRADEL HOSPITAL   (France)

Author keywords

Clinical research; Drug; Network; Paediatrics; Pharmacology; Physiology

Indexed keywords

CLINICAL PROTOCOL; CLINICAL RESEARCH; DRUG SCREENING; FRANCE; MEDICAL EDUCATION; MEDICAL RESEARCH; NURSE; PATHOPHYSIOLOGY; PEDIATRIC CLINICAL INVESTIGATION CENTER; PHARMACIST; PHYSICIAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; REVIEW;

EID: 33947711697     PISSN: 07673981     EISSN: 14728206     Source Type: Journal    
DOI: 10.1111/j.1472-8206.2007.00463.x     Document Type: Review

References (21)

1. Avenel S., Bomkratz A., Dassieu G., Janaud J.C., Danan C. The incidence of prescriptions without marketing product license in a neonatal intensive care unit. Arch Pediatr. (2000) 7 143-147.
2. Chalumeau M., Treluyer J.M., Salanave B. et al. Off label and unlicensed drug use among French office based paediatricians. Arch. Dis. Child. (2000) 83 502-505.
3. Conroy S., Choonara I., Impicciatore P. et al. Survey of unlicensed and off label drug use in paediatric wards in European countries. European Network for Drug Investigation in Children. BMJ (2000) 320 79-82.
4. Nahata M.C. Inadequate pharmacotherapeutic data for drugs in children: what can be done? Paediatr. Drugs (1999) 1 245-249.
5. Efron D., Hiscock H., Sewell J.R. et al. Prescribing of psychotropic medications for children by Australian paediatricians and child psychiatrists. Pediatrics (2003) 111 372-375.
6. Choonara I. Unlicensed and off-label drug use in children: implications for safety. Expert Opin. Drug Saf. (2004) 3 81-86.
7. Horen B., Montastruic J.L., Lapeyre-Mestre M. Adverse drug reactions and off-label drug use in paediatric outpatients. Br. J. Clin. Pharmacol. (2002) 54 665-670.
8. Neubert A., Dormann H., Weiss J. et al. The impact of unlicensed and off-label drug use on adverse drug reactions in paediatric patients. Drug Saf. (2004) 27 1059-1067.
9. Caldewell P.H.Y., Murphy S.B., Burlow P.N., Craig J.C. Clinical trials in children. Lancet (2004) 364 803-811.
10. Hampton T. Experts ponder paediatric research ethics. JAMA (2005) 294 2148-2151.
11. Chesney R.W. Children as clinical research subjects. J. Pediatr. (2005) 146 579-580.
12. Géraci-Buiche J. A comparison between European and American Legislation, in: Jacqz-Aigrain E., Choonara I. (Eds), Paediatric Clinical Pharmacology, Fontis Media, Taylor and Francis Group, New York, 2006, 25-34.
13. European Commission (2002) Better medicines for children: proposed regulatory actions on paediatric medicinal producers-consultation document. Available at: http://ec.europa.eu/enterprise/pharmaceuticals/pharmacos/docs/ doc2002/feb/cd_paediatrics_en.pdf Last accessed 14 February 2007.
14. Commission des Communautés Européennes (2004) Réglement du parlement européen et du conseil relative aux médicaments utilisés en pédiatrie, modifiant le réglement (CEE) n° 1768/92, la directive 2001/83/CE et le réglement (CEE) n° 726/2004. Availabe at: http://ec.europa.eu/ enterprise/pharmaceuticals/paediatrics/index.htm Last accessed 14 February 2007.
15. Alberti C., Giraudeau B. Specific issues in relation to clinical trials, in: Jacqz-Aigrain E., Choonara I. (Eds), Paediatric clinical pharmacology, Fontis Media, 2005, pp. 55-62.
16. Nunn T., Williams J. Formulation of medicines for children. Br. J. Clin. Pharmacol. (2005) 59 674-676.
17. Bonati M., Pandolfini C., DEC-net collaborative group. More on compulsory registration of clinical trials: complete clinical trial register is already reality for paediatrics. BMJ (2005) 330 480.
18. Burtin P., Jacqz-Aigrain E. Value of population approach in the study of pharmacokinetic variability in pediatrics. Arch. Pediatr. (1996) 3 239s-241s.
19. Johnson T.N. Modelling approaches to dose estimation in children. Br. J. Clin. Pharmacol. (2005) 59 663-669.
20. Eudipharm: a European course leading to a European Diploma in Pharmaceutical Medicine.Available at: http://www.md.ucl.ac.be/iufc/ esdp_eudipharm/ Last accessed 14 February 2007.
21. Demotes-Mainard J., Chene G., Libersa C., Pignon J.P. Clinical research infrastructures and networks in France: report on the French ECRIN workshop. Therapie (2005) 60 183-199.